| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |